The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Modern methods for delivery of drugs across the blood–brain barrier
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
Hynynen, K., McDannold, N., Vykhodtseva, N., & Jolesz, F. A. (2001) · Radiology · doi:10.1148/radiol.2202001804 · Cited by 1,456
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Tat-mediated delivery of heterologous proteins into cells.
Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225
Tight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
González-Scarano, F., & Martín-García, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1527 · Cited by 1,097
Kaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., Bland, R. J., Young, D., Strybing, K., Eidelberg, D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60982-9 · Cited by 1,067
Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., & Dowdy, S. F. (1998) · Nature Medicine · doi:10.1038/4042 · Cited by 928
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Discher, D. E., & Ahmed, F. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095838 · Cited by 844
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Yu, Y. J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., Atwal, J., Elliott, J. M., Prabhu, S., Watts, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002230 · Cited by 794
Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02004-x · Cited by 786
Crosstalk of tight junction components with signaling pathways
González-Mariscal, L., Tapia, R., & Chamorro, D. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.018 · Cited by 759
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660
Oldendorf, W. H., Cornford, M. E., & Brown, W. J. (1977) · Annals of Neurology · doi:10.1002/ana.410010502 · Cited by 655
Inflammation in stroke and focal cerebral ischemia
Huang, J., Upadhyay, U. M., & Tamargo, R. J. (2006) · Surgical Neurology · doi:10.1016/j.surneu.2005.12.028 · Cited by 649
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604318103 · Cited by 645
Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
Deli, M. A., Ábrahám, C. S., Kataoka, Y., & Niwa, M. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1377-8 · Cited by 643
Blood-brain barrier disruption in multiple sclerosis
Minagar, A., & Alexander, J. S. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms965oa · Cited by 638
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Sheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 617
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
Cardoso, F. L., Brites, D., & Brito, M. A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.003 · Cited by 569
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
ABC Transporters and the Blood-Brain Barrier
Begley, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 545
Treat, L. H., McDannold, N., Vykhodtseva, N., Zhang, Y., Tam, K., & Hynynen, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22732 · Cited by 545
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Lee, G., Dallas, S., Hong, M., & Bendayan, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01513-8 · Cited by 539
Neurotrophic and Neuroprotective Actions of Estrogens and Their Therapeutic Implications
Lee, S. J., & McEwen, B. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.569 · Cited by 534
Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides
Drin, G., Cottin, S., Blanc, E., Rees, A. R., & Temsamani, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303938200 · Cited by 530
Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Stamatovic, S., Keep, R., & Andjelkovic, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 513
Seizure‐Promoting Effect of Blood–Brain Barrier Disruption
Marchi, N., Angelov, L., Masaryk, T., Fazio, V., Granata, T., Hernandez, N., Hallene, K., Diglaw, T., Franic, L., Najm, I., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00988.x · Cited by 508
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Bhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J. M., Grazú, V., Borm, P., Estrada, G., Ntziachristos, V., & Razansky, D. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-3 · Cited by 495
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Cell-penetrating peptides: tools for intracellular delivery of therapeutics
Deshayes, S., Morris, M. C., Divita, G., & Heitz, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5109-0 · Cited by 483
Strategies to advance translational research into brain barriers
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70326-5 · Cited by 474
Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation
Abbott, N. J. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1374-y · Cited by 469
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Identification and Design of Peptides as a New Drug Delivery System for the Brain
Demeule, M., Régina, A., Ché, C., Poirier, J., Nguyen, T., Gabathuler, R., Castaigne, J.-P., & Béliveau, R. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131318 · Cited by 462
Transporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Drug and gene targeting to the brain with molecular trojan horses
Pardridge, W. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd725 · Cited by 439
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
Cao, G., Pei, W., Ge, H., Liang, Q., Luo, Y., Sharp, F. R., Lu, A., Ran, R., Graham, S. H., & Chen, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05423.2002 · Cited by 419
Doolittle, N. D., Miner, M. E., Hall, W. A., Siegal, T., Hanson, E. J., Osztie, E., McAllister, L. D., Bubalo, J. S., Kraemer, D. F., Fortin, D., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y · Cited by 399
P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs
Fromm, M. F. (2000) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38069 · Cited by 399
Human Blood—Brain Barrier Insulin Receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07167.x · Cited by 399
Transferrin and Transferrin Receptor Function in Brain Barrier Systems
Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394
Iron and Iron-Handling Proteins in the Brain After Intracerebral Hemorrhage
Wu, J., Hua, Y., Keep, R. F., Nakamura, T., Hoff, J. T., & Xi, G. (2003) · Stroke · doi:10.1161/01.str.0000103140.52838.45 · Cited by 393
Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier
Fillebeen, C., Descamps, L., Dehouck, M.-P., Fenart, L., Benaı̈ssa, M., Spik, G., Cecchelli, R., & Pierce, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7011 · Cited by 385
Deli, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.016 · Cited by 385
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
Kumar, P., Shen, Q., Pivetti, C. D., Lee, E. S., Wu, M. H., & Yuan, S. Y. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001112 · Cited by 380
Jordão, J. F., Ayala-Grosso, C. A., Markham, K., Huang, Y., Chopra, R., McLaurin, J., Hynynen, K., & Aubert, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010549 · Cited by 378
Blood-Brain Barrier Tight Junction Disruption in Human Immunodeficiency Virus-1 Encephalitis
Dallasta, L. M., Pisarov, L. A., Esplen, J. E., Werley, J. V., Moses, A. V., Nelson, J. A., & Achim, C. L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65511-3 · Cited by 372
Régina, A., Demeule, M., Ché, C., Lavallée, I., Poirier, J., Gabathuler, R., Béliveau, R., & Castaigne, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.260 · Cited by 368
Evidence of a Role for Monocytes in Dissemination and Brain Invasion by Cryptococcus neoformans
Charlier, C., Nielsen, K., Daou, S., Brigitte, M., Chretien, F., & Dromer, F. (2009) · Infection and Immunity · doi:10.1128/iai.01065-08 · Cited by 362
Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
Petty, M. A., & Lo, E. H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00128-4 · Cited by 360
Rousselle, C., Clair, P., Lefauconnier, J.-M., Kaczorek, M., Scherrmann, J.-M., & Temsamani, J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26466-x · Cited by 357
Human blood-brain barrier transferrin receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1987) · Metabolism · doi:10.1016/0026-0495(87)90099-0 · Cited by 356
Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Dohgu, S., Takata, F., Yamauchi, A., Nakagawa, S., Egawa, T., Naito, M., Tsuruo, T., Sawada, Y., Niwa, M., & Kataoka, Y. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.027 · Cited by 350
de Boer, A. G., & Gaillard, P. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105237 · Cited by 348
Heparin-Binding EGF-Like Growth Factor
National Cancer Institute (2020) · Definitions · doi:10.32388/hz52we · Cited by 345
Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy
Desai, B. S., Monahan, A. J., Carvey, P. M., & Hendey, B. (2007) · Cell Transplantation · doi:10.3727/000000007783464731 · Cited by 339
Ke, W., Shao, K., Huang, R., Han, L., Liu, Y., Li, J., Kuang, Y., Ye, L., Lou, J., & Jiang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.049 · Cited by 337
Potter, M. D., Barbero, S., & Cheresh, D. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505568200 · Cited by 337
Haorah, J., Ramirez, S. H., Schall, K., Smith, D., Pandya, R., & Persidsky, Y. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04393.x · Cited by 333
Pardridge, W. M. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00001 · Cited by 328
Santra, S., Yang, H., Holloway, P. H., Stanley, J. T., & Mericle, R. A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0464140 · Cited by 327
Brain cancer diagnosis and therapy with nanoplatforms☆
KOO, Y., REDDY, G., BHOJANI, M., SCHNEIDER, R., PHILBERT, M., REHEMTULLA, A., ROSS, B., & KOPELMAN, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.012 · Cited by 326
Kabanov, A. V., Batrakova, E. V., & Miller, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00176-x · Cited by 325
Cell Penetrating Peptides in Drug Delivery
Snyder, E. L., & Dowdy, S. F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019289.61978.f5 · Cited by 323
Zhao, M., Kircher, M. F., Josephson, L., & Weissleder, R. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0255236 · Cited by 319
Pardridge, W. M., Kang, Y.-S., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 315
Distribution and characterization of microglia/macrophages in human brain tumors
Roggendorf, W., Strupp, S., & Paulus, W. (1996) · Acta Neuropathologica · doi:10.1007/s004010050520 · Cited by 315
Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?
Garcia-Garcia, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 314
Hirase, T., Kawashima, S., Wong, E. Y. M., Ueyama, T., Rikitake, Y., Tsukita, S., Yokoyama, M., & Staddon, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007136200 · Cited by 311
Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells
Yu, A. S. L., McCarthy, K. M., Francis, S. A., McCormack, J. M., Lai, J., Rogers, R. A., Lynch, R. D., & Schneeberger, E. E. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00581.2004 · Cited by 307
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1
Sabatier, J. M., Vives, E., Mabrouk, K., Benjouad, A., Rochat, H., Duval, A., Hue, B., & Bahraoui, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.961-967.1991 · Cited by 302
Blood–brain barrier impairment in Alzheimer disease: Stability and functional significance
Bowman, G. L., Kaye, J. A., Moore, M., Waichunas, D., Carlson, N. E., & Quinn, J. F. (2007) · Neurology · doi:10.1212/01.wnl.0000262031.18018.1a · Cited by 293
Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor
Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., van Bronswijk, W., & Martins, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-j0001.2002 · Cited by 291
Cell-penetrating peptides: A comparative membrane toxicity study
Saar, K., Lindgren, M., Hansen, M., Eiríksdóttir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., & Langel, Ü. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.07.033 · Cited by 290
Lee, H. J., Engelhardt, B., Lesley, J., Bickel, U., & Pardridge, W. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35388-1 · Cited by 287
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
Li, X., Ding, L., Xu, Y., Wang, Y., & Ping, Q. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.023 · Cited by 274
Peracchia, M. T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., & Langer, R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01597-0 · Cited by 266
Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression
Huber, J. D., Witt, K. A., Hom, S., Egleton, R. D., Mark, K. S., & Davis, T. P. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h1241 · Cited by 266
Bennett, J., Basivireddy, J., Kollar, A., Biron, K. E., Reickmann, P., Jefferies, W. A., & McQuaid, S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.011 · Cited by 265
Batrakova, E. V., Li, S., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043307 · Cited by 263
Hu, K., Shi, Y., Jiang, W., Han, J., Huang, S., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.062 · Cited by 261
Role of microglia in the central nervous system's immune response
Streit, W. J., Conde, J. R., Fendrick, S. E., Flanary, B. E., & Mariani, C. L. (2005) · Neurological Research · doi:10.1179/016164105x49463a · Cited by 258
Verma, S., Lo, Y., Chapagain, M., Lum, S., Kumar, M., Gurjav, U., Luo, H., Nakatsuka, A., & Nerurkar, V. R. (2009) · Virology · doi:10.1016/j.virol.2008.11.047 · Cited by 254
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197
Giannini, G., Rappuoli, R., & Ratti, G. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.10.4063 · Cited by 251
Ultrasound for drug and gene delivery to the brain
Hynynen, K. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.010 · Cited by 250
Permeability of the blood–brain barrier depends on brain temperature
Kiyatkin, E. A., & Sharma, H. S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.004 · Cited by 248
The blood-brain barrier, chemokines and multiple sclerosis
Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247
Progress and problems in the application of focused ultrasound for blood–brain barrier disruption
Vykhodtseva, N., McDannold, N., & Hynynen, K. (2008) · Ultrasonics · doi:10.1016/j.ultras.2008.04.004 · Cited by 245
Protein kinase signaling in the modulation of microvascular permeability
Yuan, S. Y. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00010-7 · Cited by 242
Physiology and pharmacological role of the blood-brain barrier.
Bernacki, J., Dobrowolska, A., Nierwińska, K., & Małecki, A. (2008) · PubMed · Cited by 238
Harhaj, N. S., Felinski, E. A., Wolpert, E. B., Sundstrom, J. M., Gardner, T. W., & Antonetti, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0322 · Cited by 238
Morantz, R. A., Wood, G. W., Foster, M., Clark, M., & Gollahon, K. (1979) · Journal of Neurosurgery · doi:10.3171/jns.1979.50.3.0305 · Cited by 238
Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review
MOOS, T., & MORGAN, E. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.002 · Cited by 234
Deane, R., Sagare, A., Hamm, K., Parisi, M., LaRue, B., Guo, H., Wu, Z., Holtzman, D. M., & Zlokovic, B. V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3697-05.2005 · Cited by 233
Sterically stabilized liposome therapeutics
Woodle, M. C. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00028-6 · Cited by 228
Mechanisms of the Blood–Brain Barrier Disruption in HIV-1 Infection
Toborek, M., Lee, Y. W., Flora, G., Pu, H., András, I. E., Wylegala, E., Hennig, B., & Nath, A. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1383-x · Cited by 228
Thomas, F. C., Taskar, K., Rudraraju, V., Goda, S., Thorsheim, H. R., Gaasch, J. A., Mittapalli, R. K., Palmieri, D., Steeg, P. S., Lockman, P. R., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9964-5 · Cited by 226
High transcytosis of melanotransferrin (P97) across the blood–brain barrier
Demeule, M., Poirier, J., Jodoin, J., Bertrand, Y., Desrosiers, R. R., Dagenais, C., Nguyen, T., Lanthier, J., Gabathuler, R., Kennard, M., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01201.x · Cited by 221
Habgood, M. D., Bye, N., Dziegielewska, K. M., Ek, C. J., Lane, M. A., Potter, A., Morganti‐Kossmann, C., & Saunders, N. R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05275.x · Cited by 220
Molecular Biology of the Blood–Brain Barrier
Pardridge, W. M. (2005) · Molecular Biotechnology · doi:10.1385/mb:30:1:057 · Cited by 220
Breaking down the barrier: The effects of HIV-1 on the blood–brain barrier
Strazza, M., Pirrone, V., Wigdahl, B., & Nonnemacher, M. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.015 · Cited by 218
Batrakova, E. V., Li, S., Miller, D. W., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018990706838 · Cited by 206
Boado, R. J., Zhang, Y., Zhang, Y., & Pardridge, W. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21120 · Cited by 203
Pathogenesis of Cerebral Cryptococcus neoformans Infection after Fungemia
Chrétien, F., Lortholary, O., Kansau, I., Neuville, S., Gray, F., & Dromer, F. (2002) · The Journal of Infectious Diseases · doi:10.1086/341564 · Cited by 201
Pardridge, W. M., Boado, R. J., & Kang, Y. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5592 · Cited by 195
CNS Drug Delivery Systems: Novel Approaches
Pathan, S., Iqbal, Z., Zaidi, S., Talegaonkar, S., Vohra, D., Jain, G., Azeem, A., Jain, N., Lalani, J., Khar, R., et al. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109787158355 · Cited by 193
Daleke, D. L., Hong, K., & Papahadjopoulos, D. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90365-u · Cited by 193
Lu, W., Wan, J., She, Z., & Jiang, X. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.015 · Cited by 193
Angiogenesis of the blood‐brain barrier in vitro and the function of cerebral pericytes
Ramsauer, M., Krause, D., & Dermietzel, R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0814fje · Cited by 192
Shao, K., Huang, R., Li, J., Han, L., Ye, L., Lou, J., & Jiang, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.018 · Cited by 191
Williams, K., Alvarez, X., & Lackner, A. A. (2001) · Glia · doi:10.1002/glia.1105 · Cited by 190
Tumour necrosis factor-α causes an increase in blood-brain barrier permeability during sepsis
TSAO, N., HSU, H. P., WU, C. M., LIU, C. C., & LEI, H. Y. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-9-812 · Cited by 189
Kateb, B., Chiu, K., Black, K. L., Yamamoto, V., Khalsa, B., Ljubimova, J. Y., Ding, H., Patil, R., Portilla-Arias, J. A., Modo, M., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.105 · Cited by 188
Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain
van Rooy, I., Mastrobattista, E., Storm, G., Hennink, W. E., & Schiffelers, R. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.014 · Cited by 188
Djukic, M. (2006) · Brain · doi:10.1093/brain/awl206 · Cited by 188
Recht, L., Torres, C. O., Smith, T. W., Raso, V., & Griffin, T. W. (1990) · Journal of Neurosurgery · doi:10.3171/jns.1990.72.6.0941 · Cited by 185
Pluronic P85 Enhances the Delivery of Digoxin to the Brain: In Vitro and in Vivo Studies
Batrakova, E. V., Miller, D. W., Li, S., Alakhov, V. Y., Kabanov, A. V., & Elmquist, W. F. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38781-6 · Cited by 182
Interferon-β directly influences monocyte infiltration into the central nervous system
Floris, S., Ruuls, S. R., Wierinckx, A., van der Pol, S. M. A., Döpp, E., van der Meide, P. H., Dijkstra, C. D., & De Vries, H. E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00098-x · Cited by 179
Kemper, E. M., Boogerd, W., Thuis, I., Beijnen, J. H., & van Tellingen, O. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.04.001 · Cited by 177
Lysophosphatidic Acid Increases Tight Junction Permeability in Cultured Brain Endothelial Cells
Schulze, C., Smales, C., Rubin, L. L., & Staddon, J. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68030991.x · Cited by 175
Anderson, P. (1983) · Infection and Immunity · doi:10.1128/iai.39.1.233-238.1983 · Cited by 174
Carrier-mediated or specialized transport of drugs across the blood–brain barrier
Tsuji, A., & Tamai, I. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00084-2 · Cited by 174
Spudich, A., Kilic, E., Xing, H., Kilic, Ü., Rentsch, K. M., Wunderli-Allenspach, H., Bassetti, C. L., & Hermann, D. M. (2006) · Nature Neuroscience · doi:10.1038/nn1676 · Cited by 174
The Gut Immune Barrier and the Blood-Brain Barrier: Are They So Different?
Daneman, R., & Rescigno, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.012 · Cited by 167
Zhang, Y., & Pardridge, W. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03108-5 · Cited by 167
Pharmacokinetics and brain uptake of lactoferrin in rats
Ji, B., Maeda, J., Higuchi, M., Inoue, K., Akita, H., Harashima, H., & Suhara, T. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.05.085 · Cited by 166
Intravenous TAT–Bcl‐Xl is protective after middle cerebral artery occlusion in mice
Kilic, E., Dietz, G. P. H., Hermann, D. M., & Bähr, M. (2002) · Annals of Neurology · doi:10.1002/ana.10356 · Cited by 166
Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes
Hatakeyama, H., Akita, H., Ishida, E., Hashimoto, K., Kobayashi, H., Aoki, T., Yasuda, J., Obata, K., Kikuchi, H., Ishida, T., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.037 · Cited by 165
RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting
Jain, S., Mishra, V., Singh, P., Dubey, P. K., Saraf, D. K., & Vyas, S. P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00269-2 · Cited by 164
Lim, J. C., Kania, K. D., Wijesuriya, H., Chawla, S., Sethi, J. K., Pulaski, L., Romero, I. A., Couraud, P. O., Weksler, B. B., Hladky, S. B., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05537.x · Cited by 164
Miller, D. W., Batrakova, E. V., Waltner, T. O., Alakhov, V. Y., & Kabanov, A. V. (1997) · Bioconjugate Chemistry · doi:10.1021/bc970118d · Cited by 163
Drug Delivery Across the Blood-Brain Barrier
Chen, Y., Dalwadi, G., & Benson, H. (2004) · Current Drug Delivery · doi:10.2174/1567201043334542 · Cited by 162
Self-citationEffect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters
Batrakova, E. V., Li, S., Li, Y., Alakhov, V. Y., & Kabanov, A. V. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7675-5 · Cited by 158
Bajetto, A., Barbieri, F., Dorcaratto, A., Barbero, S., Daga, A., Porcile, C., Ravetti, J. L., Zona, G., Spaziante, R., Corte, G., et al. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.003 · Cited by 158
Bender, A. R., von Briesen, H., Kreuter, J., Duncan, I. B. R., & Rübsamen‐Waigmann, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1467 · Cited by 155
The use of cell-penetrating peptides for drug delivery
Temsamani, J., & Vidal, P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03279-9 · Cited by 153
Clarke, H., Soler, A. P., & Mullin, J. M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.18.3187 · Cited by 153
Verma, S., Kumar, M., Gurjav, U., Lum, S., & Nerurkar, V. R. (2010) · Virology · doi:10.1016/j.virol.2009.10.036 · Cited by 151
Wu, D., Yang, J., & Pardridge, W. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119708 · Cited by 147
Endothelial Vesicles in the Blood–Brain Barrier: Are They Related to Permeability?
Stewart, P. A. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007026504843 · Cited by 145
Hynynen, K., McDannold, N., Martin, H., Jolesz, F. A., & Vykhodtseva, N. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(02)00741-x · Cited by 144
Desbaillets, I., Tada, M., de Tribolet, N., Diserens, A., Hamou, M., & Meir, E. G. V. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580216 · Cited by 143
Polymeric micelles anchored with TAT for delivery of antibiotics across the blood–brain barrier
Liu, L., Venkatraman, S. S., Yang, Y. Y., Guo, K., Lu, J., He, B., Moochhala, S., & Kan, L. (2008) · Biopolymers · doi:10.1002/bip.20998 · Cited by 143
Self-citationPathway across blood-brain barrier opened by the bradykinin agonist, RMP-7
Sanovich, E. Y., Bartus, R. T., Friden, P. M., Dean, R. L., Le, H. Q., & Brightman, M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01143-9 · Cited by 142
ABC efflux transporters in brain vasculature of Alzheimer's subjects
Wijesuriya, H. C., Bullock, J. Y., Faull, R. L. M., Hladky, S. B., & Barrand, M. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.034 · Cited by 142
Borlongan, C. V., & Emerich, D. F. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00043-1 · Cited by 142
Batrakova, E. V., Han, H.-Y., Miller, D. W., & Kabanov, A. V. (1998) · Pharmaceutical Research · doi:10.1023/a:1011942814300 · Cited by 141
Schröder, U., & Sabel, B. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01375-x · Cited by 141
3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier
Wade, L. A., & Katzman, R. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90248-9 · Cited by 140
Wang, H., Xu, K., Liu, L., Tan, J. P. K., Chen, Y., Li, Y., Fan, W., Wei, Z., Sheng, J., Yang, Y. Y., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.042 · Cited by 140
Self-citationArunothayanun, P., Bernard, M.-S., Craig, D. Q. M., Uchegbu, I. F., & Florence, A. T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00362-8 · Cited by 137
Gottfreðsson, M., & Perfect, J. R. (2000) · Seminars in Neurology · doi:10.1055/s-2000-9394 · Cited by 136
Duchini, A., Govindarajan, S., Santucci, M. B., Zampi, G., & Hofman, F. M. (1996) · PubMed · Cited by 135
Leveugle, B., Spik, G., Perl, D. P., Bouras, C., Fillit, H. M., & Hof, P. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90202-x · Cited by 132
Macrophages in experimental and human brain tumors
Morantz, R. A., Wood, G. W., Foster, M., Clark, M., & Gollahon, K. A. (1979) · Journal of neurosurgery · doi:10.3171/jns.1979.50.3.0298 · Cited by 131
Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes
Afergan, E., Epstein-Barash, H., Dahan, R., Koroukhov, N., Rohekar, K., Danenberg, H. D., & Golomb, G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.017 · Cited by 130
Rogers, W. J., & Basu, P. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.017 · Cited by 129
Thr207 of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP
Soma, T., Chiba, H., Kato‐Mori, Y., Wada, T., Yamashita, T., Kojima, T., & Sawada, N. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.012 · Cited by 129
Willis, C. L., Leach, L., Clarke, G., Nolan, C. C., & Ray, D. E. (2004) · Glia · doi:10.1002/glia.20049 · Cited by 127
The role of the blood–CNS barrier in CNS disorders and their treatment
Palmer, A. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.029 · Cited by 124
Tosi, G., Vergoni, A. V., Ruozi, B., Bondioli, L., Badiali, L., Rivasi, F., Costantino, L., Forni, F., & Vandelli, M. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.008 · Cited by 124
Warren, K. E., Jakacki, R. I., Widemann, B. C., Aikin, A. A., Libucha, M., Packer, R. J., Vézina, G., Reaman, G. H., Shaw, D., Krailo, M., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0172-7 · Cited by 123
Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain
Huang, R., Ke, W., Qu, Y., Zhu, J., Pei, Y., & Jiang, C. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9121-7 · Cited by 123
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa, E., Pampalakis, G., Niarakis, A., Romero, I. A., Weksler, B., Couraud, P.-O., & Antimisiaris, S. G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.015 · Cited by 122
Liu, X.-M., Pramoda, K. P., Yang, Y. Y., Chow, S. Y., & He, C. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.028 · Cited by 122
Cited by
Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., Yin, V. P., Lockman, P., & Bai, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1593-y · Cited by 975
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.005 · Cited by 704
Neural recording and modulation technologies
Chen, R., Canales, A., & Anikeeva, P. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.93 · Cited by 655
Metadata
- Authors
- Chen, Y., & Liu, L.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 64
- Issue
- 7
- Pages
- 640-665
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2077128382
- Cited by
- 1,006
- References
- 289
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.